Transcription of the gene coding for cyclin A, a protein required for S-phase transit, is cell cycle regulated and is restricted to proliferating cells. To further explore transcriptional regulation linked to cell division cycle control, a genomic clone containing 5 flanking sequences of the murine cyclin A gene was isolated. When it was fused to a luciferase reporter gene, it was shown to function as a proliferation-regulated promoter in NIH 3T3 cells. Transcription of the mouse cyclin A gene is negatively regulated by arrest of cell proliferation. A mutation of a GC-rich sequence conserved between mice and humans is sufficient to relieve transcriptional repression, resulting in a promoter with constitutively high activity. In agreement with this result, in vivo footprinting reveals a protection of the cell cycle-responsive element in G 0 /early G 1 cells which is not observed at later stages of the cell cycle. Moreover, the footprint is present in dimethyl sulfoxide-induced differentiating and not in proliferating Friend erythroleukemia cells. Conversely, two other sites, which in vitro bind ATF-1 and NF-Y, respectively, are constitutively occupied throughout cell cycle progression.
Cyclins are a family of proteins involved in the control of the eukaryotic cell division cycle. As regulatory subunits of a particular subset of periodically activated protein kinases, they control the temporal transition between the various stages of the cell cycle (for reviews, see references 18, 38, 48, 49, 59, and 60) . Their dysregulation has also been proposed to be associated with the genesis of some human cancers (8, 23, 26, 31, 32, 52, 56, 67, 68) . The A-type cyclin has been implicated in the control of the entry into S phase, as well as in the G 2 /M transition (22, 47, 53, 66) , by binding to the cdk2 and cdc2 kinases, respectively (51, 65) . Cyclin A mutants of Drosophila embryos arrest in G 2 (36, 37) . In addition to its role in the dependence of mitosis on S-phase completion, it may have a role in mitotic control (37, 63, 66) . Cyclin A is found in cellular activities which promote both replication (10, 19, 47, 50, 53, 62) and transcription (for reviews, see references 35, 45, 69) . In the former case, it has been shown to be associated with replication complexes and is likely to directly participate in the phosphorylation of replication protein A (RPA) (20, 70) . In the latter case, its association with the E2F/DRTF1 family of transcription factors has been proposed to play a central role in cell cycle transcriptional control. A large body of evidence suggests that cyclin-dependent kinases participate in the regulation of the activity of this transcription complex. This is believed to occur either directly, by the phosphorylation of E2F by cyclin A-cdk2 kinase, or indirectly through the phosphorylation of a group of proteins structurally related to RB, the retinoblastoma susceptibility gene product, by cyclins D, E, and A, which are associated with cdk4, cdk6, and cdk2 kinases. In agreement with these ideas, cyclin A is found complexed with E2F in late G 1 phase and during S phase, recruiting the catalytic kinase subunit to the DNA-binding complex (9, 17, 24, 35, 39, 46, 61, 71) .
Cyclin A mRNA and protein accumulate at the end of G 1 phase and rapidly reach a plateau during S phase, after a transcriptional activation of its gene (4, 5, 25) . We describe here studies aimed at understanding the mechanisms of cell cycle regulation of cyclin A gene transcription. We have isolated a genomic DNA fragment containing the 5Ј flanking portion of the mouse cyclin A gene and show that it directs the transcription of a luciferase reporter activity in a fashion similar to that of the endogenous gene. A sequence conserved between mice and humans has an in vivo occupancy which varies according to the proliferative status of the cells. Its mutation abolishes the repression of the cyclin A promoter in quiescent cells, thus resulting in a constitutive activity.
MATERIALS AND METHODS
Isolation of the mouse cyclin A promoter and construction of reporter plasmids. The mouse genomic library (a generous gift from J. P. Rouault) was obtained by inserting DNA from mouse CGR8 embryonic stem cells into the BamHI sites of phage EMBL3, after partial digestion with MboI. After plating on nylon filters, phages were screened with a full-length human cDNA probe (68) , and positive clones were rescreened first with a small restriction fragment corresponding to the 5Ј part of the cDNA and then with diverse 5Ј flanking sequences at low stringency. Two clones gave positive scores and were used for further analysis. The phage insert was cut with several restriction enzymes, and the resulting fragments were subcloned into pBluescript KS plasmid (Stratagene). Sequencing of double-stranded DNA fragments was carried out by the dideoxynucleotide chain termination method with T7 DNA polymerase (Pharmacia) and primers derived from plasmid and insert sequences. Selected fragments were inserted into the promoterless plasmid pGL2-Basic, containing the firefly luciferase gene as a reporter (Promega). The two oligonucleotides corresponding to the cyclin A cell cycle-responsive element (CCRE), 5Ј-CGCGTAG TCGCGGGCTAC and 5Ј-TCGAGTAGCCCGCGACTA, were annealed, and the resulting double-stranded oligonucleotide was cloned into the MluI and XhoI sites of pGL3-Promoter (Promega). The latter plasmid transcribes the luciferase gene from a minimal, enhancerless early simian virus 40 (SV40) promoter.
Mutagenesis. A splice overlap extension PCR technique was used for the genesis of the different mutations with the following oligonucleotides which introduce an EcoRI site at the selected position: (i) GC-rich (CCRE) site, 5Ј-GTAGAATTCGACTATTGAAATAAACCAATGAGGG and 5Ј-GTCGAA TTCTACTTGAACTACAAGACCAG; (ii) NF-1/NF-Y 5Ј half, 5Ј-CCCGAATT CGTTTATTTCAATAGTCGCGG and 5Ј-AACGAATTCGGGCGTCCGGAG TC; and (iii) NF-1/NF-Y 3Ј half, 5Ј-GGGAATTCTAGTCGCGGCTACTTG and 5Ј-CTAGAATTCTAAACCAATGAGGGCG. The reconstituted full-length fragments were all amplified with the following oligonucleotides, which allow cloning into the KpnI and HindIII sites of pGL2-Basic: 5Ј-CGCGGTACCTATG AGGCTACAGATC and 5Ј-GGGAAGCTTCTGCAGGCGGGAGGA. All mutations were verified by sequencing.
RNase protection and primer extention assays. A 278-bp BamHI-PstI mouse DNA fragment containing the putative transcription initiation site(s) subcloned into pBluescript SK ϩ was used to synthesize a uniformly labeled probe with [␣-32 P]UTP (400 Ci/mmol; Amersham) and T3 RNA polymerase (Boehringer) as indicated by the suppliers. After digestion of the template with 15 U of RNase-free DNase (Bethesda Research Laboratories) for 15 min at 37ЊC, RNA was extracted with phenol-chloroform and precipitated with 2 volumes of ethanol in the presence of 10 g of yeast tRNA. The radioactive RNA was fractionated by electrophoresis through a 5% polyacrylamide-8 M urea gel, hybridized to 50 g of total RNA prepared from exponentially growing NIH 3T3 cells, and digested with RNase A. The resulting protected bands were extracted with solvent, ethanol precipitated in the presence of carrier tRNA, and resolved on a 5% polyacrylamide sequencing gel in parallel with labeled size markers and a sequence ladder from the same region.
The synthetic oligonucleotide 5Ј-GGGAAGCTTCTGCAGGCGCCAGGA (50 ng) was labeled with [␥-
32 P]ATP (3,000 Ci/mmol; Amersham) and polynucleotide kinase. Primer extention was performed with avian myeloblastosis virus reverse transcriptase after hybridization to poly(A) ϩ RNA purified from 200 g of total RNA. Elongated products were analyzed on the type of sequencing gels described above.
Cell culture and transfections. Mouse NIH 3T3 cells and human fibroblasts from skin biopsies were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum. A total of 2 ϫ 10 5 cells per 3.5-cm-diameter dish were transfected by the calcium phosphate method with 4 g of total DNA as described elsewhere (6) . The cells were synchronized with a 48-h culture in 0.5% serum and then by refeeding with complete medium. After cell lysis at the indicated times, luciferase activities were measured with a Lumat LB9501 Berthold luminometer. When necessary, [ 3 H]thymidine incorporation into acidprecipitable radioactivity was monitored by standard procedures.
Friend leukemia cells derived from the 745A clone were grown in RPMI 1640 medium supplemented with 10% fetal calf serum and were differentiated by the addition of 1.5% (vol/vol) dimethyl sulfoxide (DMSO) as described elsewhere (43) .
In vivo genomic footprint analysis. Cells from 9-cm petri dishes were exposed for 2 min to 1 l of dimethyl sulfate (DMS) per ml, and the reaction was quenched with 2% ␤-mercaptoethanol and then by washing in phosphate-buffered saline (PBS). After extraction of genomic DNA and piperidine cleavage of methylated guanines, methylation interference was monitored by a ligationmediated PCR as described elsewhere (6, 21) . The following oligonucleotides were used for the sense-strand analysis: 5Ј-GCGGGAGGAGCGTAGAGCCC, 5Ј-AGCCCAGGAGCCGCGAGCTG, and 5Ј-CAGGAGCCGCGAGCTGCG CG. For the antisense strand, the following oligonucleotides were used: 5Ј-CCT CAGGCTCCCGCCCTGTAAGATT, 5Ј-CTGTAAGATTCCCGTCGGGCCT TCG, and 5Ј-AAGATTCCCGTCGGGCCTTCGCTCG. The last oligonucleotide was labeled with T4 polynucleotide kinase and [␥-32 P]ATP as described above, and radioactive elongated DNA was fractionated on a 6% polyacrylamide sequencing gel.
Flow cytometry and cell cycle analysis. Quantitative fluorescence analysis was performed with a fluorescence-activated cell sorter (FACS) Ventage (Becton Dickinson, Mountain View, Calif.) equipped with an argon ion 90.3 laser (Coherent, Palo Alto, Calif.) tuned at 488 nm (250 mW). Cells were treated for 2 min at room temperature with 1 l of DMS per ml and then with 2% ␤-mercaptoethanol prior to cell sorting. The cells were stained by propidium iodide (65 g/ml) after permeabilization in PBS containing 0.1% Triton X-100. Each selected population (1 ϫ 10 6 to 2 ϫ 10 6 cells) was reanalyzed with a FACScan (Becton Dickinson) to evaluate its purity (92 to 99% within the gated region), and the DNA was processed as described above.
Gel mobility shifts. The following double-stranded oligonucleotides corresponding, respectively, to the Sp1 and E2F consensus sites, as well as the cyclin A cyclic AMP (cAMP)-responsive element (CRE), the NF-Y, and the CCRE sites, were used: SP1, 5Ј-ATTCGATCGGGGCGGGGCGAGC; E2F, 5Ј-ATTT AAGTTTCGCGCCCTTTCTCAA; CRE, 5Ј-GGGTCGCCTTGAATGACGTC AAGGCCGCGA; NF-Y, 5Ј-GAGCGCTTTCATTGGTCCATTT; CCRE, 5Ј-G GGATTTCAATAGTCGCGGGCTACTTGAA.
When indicated, the following mutated oligonucleotides were also used: mE2F, 5Ј-ATTTAAGTTTCGATCCCTTTCTCAA; mCRE, 5Ј-GGGTCGCCT TCAACGACCTCGAGGCCGCGA; mNF-Y, 5Ј-GAGCGCTTGAATTCGTC CATTT; mCCRE, 5Ј-GGGATTTCAATAGTCGAATTCTACTTGAA. The annealed oligonucleotides described above were either end-labeled with T4 polynucleotide kinase and [␥- 
RESULTS

Isolation of the mouse cyclin A promoter.
A mouse genomic library was screened with a full-length human cyclin A cDNA probe (68) . Positive clones were selected for further study by hybridization at low stringency with probes derived from the 5Ј flanking sequence of the human gene (25) . A phage clone characterized during this analysis contained a 15-kb insert whose sequence revealed regions of similarity leading to its identification as a genomic copy of the mouse cyclin A gene (data not shown). Sequencing upstream of the 5Ј-most region of homology with the human cDNA sequence revealed the presence of a highly conserved nucleotide stretch (underlined in Fig. 1A ). Like its human counterpart, the murine sequence showed no canonical TATA box. To map precisely the transcription initiation site(s), an RNase protection experiment was carried out on total RNA extracted from exponentially growing NIH 3T3 cells. At variance with the highly heterogeneous initiation described for the human promoter (25) , three major initiation sites and a fourth, weaker initiation site were clearly visible for the mouse promoter (Fig. 1B) . The positions were confirmed by primer extension with a set of two internal oligonucleotides (data not shown).
A closer inspection of the DNA sequence within the conserved fragment pointed to the existence of three motifs, which were previously described for the human promoter: CRE, an NF-1/NF-Y site, and a GC-rich E2F/SP1-like sequence, which are exactly conserved in the mouse promoter (Fig. 1C) . Surprisingly, these elements are positioned downstream from the first three initiation sites.
An EcoRI-PstI DNA fragment spanning nucleotides Ϫ795 to ϩ100 relative to the 3Ј-most initiation site was linked to the firefly luciferase gene to check if the isolated putative promoter-proximal fragment was functional after transient transfection into NIH 3T3 cells. As shown in Fig. 2 , only very low levels of luciferase activity were detected in cycling cells transfected with the promoter-less pGL2-Basic vector. In contrast, the fragment from Ϫ795 to ϩ100 fragment gave rise to a 280-fold stimulation of luciferase activity when it was inserted in the sense orientation. The same fragment inserted in the antisense orientation was totally inactive in the same test. A shorter construct (nucleotides Ϫ177 to ϩ100), which was derived by recutting the former DNA fragment with BamHI, elicited an even stronger activation (1,170-fold). However, reduction down to ϩ20 almost completely abolished promoter activity, indicating the presence of important elements controlling cyclin A transcription within the DNA fragment from nucleotides Ϫ177 to ϩ20.
An in vivo footprint is present on the GC-rich motif only in quiescent cells. To analyze in more detail the mechanism involved in the serum inducibility of cyclin A gene transcription, we performed an in vivo footprint analysis of the region containing the conserved upstream promoter sequence. Cells were rendered quiescent by serum starvation and were then restimulated with fresh serum. At each indicated time of treatment, cells were exposed to DMS and genomic DNA was processed for the detection of hypomethylated guanine residues as described elsewhere (6, 21) . A clear protection was visible on both the CRE and the GC-rich (CCRE [see below]) motifs in quiescent cells, together with a weaker but significant protection of the NF-1/NF-Y site (Fig. 3, left panel) . However, whereas the CRE and the NF-1/NF-Y sites were protected whatever the time point selected for the stimulated cells, the GC-rich motif became progressively exposed as cells progressed toward S phase. The footprint was no longer visible in exponentially growing cells.
The good conservation of the sequence between the human and mouse promoters prompted us to carry out the same type of analysis on normal human fibroblasts which were growth arrested either by serum starvation or by treatment with transforming growth factor ␤1 (TGF-␤1). TGF-␤1 belongs to a family of cytokines with multifunctional properties as diverse as the control of cell proliferation, cell differentiation, or cell adhesion and migration (for reviews, see references 1, 33, 42, 54) . It inhibits the proliferation of many cell lines by negatively regulating progression through the G 1 phase of the cell cycle FIG. 2. Promoter activity directed by mouse cyclin A genomic DNA fragments. Growing NIH 3T3 cells were transfected as indicated, and luciferase activity was monitored 24 h later. An EcoRI-PstI (Ϫ795 to ϩ100) genomic fragment was inserted in both sense and antisense orientations into the pGL2-Basic promoterless vector [pGL2(Ϫ795,ϩ100) CycA]. (Ϫ177,ϩ100) and (ϩ20,ϩ100), constructs in which deletions were introduced starting from the 5Ј side of the initial (Ϫ795 to ϩ100) insert cloned in the sense orientation. Values are the averages of three independent experiments, and standard deviations are shown. RLU, relative luciferase units (normalized for ␤-galactosidase activity). P-labeled, 377-nucleotide-long antisense RNA probe. Numbers on the left, sizes of the protected RNA fragments indicated by arrows; numbers on the right, lengths of HpaII-cut pUC-labeled DNA fragments run in the same gel, together with a sequence ladder obtained after sequencing of the region including the putative initiation sites. The probe was degraded after hybridization to either 50 g of tRNA (tRNA) or 50 g of RNA extracted from cycling NIH 3T3 cells (NIH) or was incubated alone (probe). Protected fragments were separated on a standard 5% polyacrylamide sequencing gel and autoradiographed as indicated. (C) Comparison of the sequences of mouse and human 5Ј-flanking DNA regions. The numbers for the human sequence refer to those used by Henglein et al. (25) . Sequences for a CRE and a putative NF-1/ NF-Y site and a GC-rich conserved sequence are underlined.
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on February 21, 2013 by PENN STATE UNIV http://mcb.asm.org/ (11, 42, 54) . A specific protection was observed for the GC-rich motif in quiescent cells, while no protection of this site was detectable after 17 h of serum refeeding the same cells or in normally cycling cells (Fig. 3, right panel) . In contrast, the CRE and NF-1/NF-Y sites were always found protected in quiescent, stimulated, and normally cycling cells, in agreement with our previous observation (6).
To rule out any artifacts arising from the starvation-based synchronization procedure, we repeated this analysis on cells selected by preparative cell sorting of an exponentially growing cell population. While the preliminary experiments were carried out on NIH 3T3 cells, we finally selected mouse Friend erythroleukemic cells, which grow in suspension, in order to avoid any artifacts potentially generated by the trypsinization step. The results obtained with cells which were, respectively, in the G 0 , G 1 , S, and G 2 /M phases of the cell division cycle are shown in Fig. 4 . A maximal protection of the GC-rich motif was observed only for cells in G 0 on both the sense and antisense strands. Interestingly, in the latter case, a strong hypersensitive site was also present next to the GC-rich motif only in quiescent cells and vanished progressively when the cells reached S phase. To get a better estimate of the period during which the footprint present on the GC-rich element is released when cycling cells transit through the G 1 phase of the cell cycle, cells were blocked with demecolcine at the G 2 /M border. After a 9.5-h treatment with 100 nM demecolcine, Friend cells were extensively washed and their progression through the cell cycle was monitored by FACS analysis (Fig. 5 ). Cells were processed for genomic footprinting at various time intervals, and the protected bands within the GC-rich sequence were submitted to a densitometric analysis. The quantitative result, integrating 13 different experiments, is shown in Fig. 5 for the band labeled A in Fig. 4 . The footprint is prominent in early G 1 (1.5 h post-demecolcine block) and is released in mid-G 1 (4 h postdemecolcine block). Another advantage in using Friend cells is that as erythroid precursor cells, they can undergo upon addition of inducers such as DMSO, a differentiation program closely resembling the final stage of normal erythrocytes (43) . When Friend cells were treated with 1.5% (vol/vol) DMSO, their growth rate was not affected for at least 4 days and then reached a plateau after 5 days of culture in the presence of the inducer (data not shown [43] ). In a parallel way, a large proportion of the cells differentiated, as revealed by the increase in hemoglobin content, which was measured by benzimidine staining (Fig. 6) . As a consequence of the DMSO-induced cell growth arrest, the footprint on the GC-rich element, which was absent in growing cells, built up progressively as cells entered a differentiated, quiescent state.
These data are consistent with the existence of a negative factor mediating the inhibition of the cyclin A promoter in quiescent and early G 1 cells through its binding to the upstream GC-rich motif.
The cyclin A promoter is under negative control in quiescent cells. Previous work carried out on the human promoter had shown that the late G 1 /S accumulation of cyclin A mRNA upon release from G 0 is the consequence of transcriptional activation of the gene (6, 25) . To delineate sequences important for cell cycle control of cyclin A expression, we have used promoter-luciferase gene fusions in transient transfection assays carried out in mouse NIH 3T3 growth-arrested cells. Because both the fragments from Ϫ795 to ϩ100 and from Ϫ177 to ϩ100 gave rise to the same induction kinetics upon serum addition (data not shown), the shorter fragment was selected for the subsequent part of this analysis. We have already shown that the cyclin A promoter is down-regulated by TGF-␤1 and cAMP in human and hamster fibroblasts through the CRE. However, a CRE mutant was still able to respond, albeit with a lower efficiency, to serum stimulation (5, 6) . This observation, in conjunction with the in vivo footprint data reported above, suggests that the region next to the CRE, and likely the GC-rich motif, could be the CCRE. To resolve this issue, NIH 3T3 cells grown for 36 h in the presence of 0.5% calf serum were transfected with vectors containing either a wild-type (pGL2-CycA) promoter or a mutated (pGL2-CycAm) promoter, in which the GCGGGG had been changed into GAATTC. After exposure to 10% serum, luciferase activities were monitored for the indicated times and were normalized to ␤-galactosidase expressed from a cell cycle-insensitive promoter. The entry of stimulated cells into S phase was monitored by [ 3 H]thymidine incorporation in parallel plates (Fig.  7A) . For the wild-type construct, luciferase activity began to increase significantly 10 h after refeeding the cells with serum, with a maximum of 18-to 20-fold stimulation at 12 h (Fig. 7B) . In contrast, an almost constitutive activity, with variations which remained within a factor of 2, was observed for the mutant promoter (Fig. 7C) . Moreover, luciferase activity directed by the mutant promoter was approximately 10-fold The same type of analysis was performed on human primary fibroblasts that were either serum starved (serum arrested), exponentially growing (exponential), or serum restimulated either alone (17 h serum stimulated) or in the presence of 10 ng of TGF-␤ per ml (stimulated ϩ TGF-␤). Arrows, protected G sites; asterisks, hypersensitive sites. Note that the amount of in vitro-methylated DNA is slightly less in the right panel, so that the protection appears weaker for this particular set of experiments.
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on February 21, 2013 by PENN STATE UNIV http://mcb.asm.org/ higher than that observed for the wild-type promoter (Fig.  7D) . Mutation of the putative NF-1/NF-Y site located 5Ј relative to the GC-rich element did not abolish the response to serum and only mildly affected its amplitude (data not shown). We will use the abbreviation CCRE to describe the GC-rich site in the rest of this work. The cyclin A CCRE functions as an inhibitory element in a heterologous promoter. The absence of variation upon release from quiescence after serum refeeding, as well as the 10-foldhigher transcriptional activity supported by the mutated promoter, prompted us to test the inhibitory effect of the CCRE on a heterologous promoter. To this end, we inserted an oligonucleotide containing the sequence TAGTCGCGGGATAC into the MluI and XhoI sites of pGL3-Promoter vector (Promega), in which the luciferase gene is transcribed from an early SV40 promoter. The SV40 promoter is not cell cycle regulated and was stimulated to a modest level upon serum addition (1.5-2 fold; Fig. 8A ). Introduction of the CCRE sequence resulted in a dramatic decrease in promoter activity (8-to 10-fold), confirming its inhibitory effect. However, the observed inhibition was no longer cell cycle dependent, suggesting that other elements participate in the cell cycle activity of the cyclin A CCRE. In order to further analyze the contribution of sequences surrounding the CCRE to its activity, we inserted the HaeIII-NaeI fragment spanning nucleotides Ϫ60 to ϩ45, in both orientations, into the SmaI site of pGL3-Promoter. In the antisense orientation, the fragment from Ϫ60 to ϩ45 did not give rise to a strong inhibition of the SV40 promoter, and it did not restore a cell cycle-dependent behavior (Fig. 8B) . However, the same fragment in the sense orientation led to a 7-to 10-fold reduction of promoter activity in quiescent cells (data not shown) and a 6-to 8-fold induction upon serum refeeding (Fig. 8B) . The same DNA fragment containing a mutated CCRE was ineffective in restoring the cell cycle-regulated phenotype.
Proteins binding in vitro to the various elements present within the cyclin A promoter. Nuclear extracts were prepared from quiescent NIH 3T3 cells and NIH 3T3 cells that were serum refed for 16 h and were used in mobility shift assays carried out with 32 P-labeled, double-stranded oligonucleotides containing either the CRE, the NF-1/NF-Y, or the cyclin A CCRE motifs.
It has previously been shown that the cyclin A CRE was able to bind equally well in vitro synthesized CREB and ATF-1 proteins (6, 16) . We show here that in the presence of a specific anti-ATF-1 antibody, specific complexes formed by nuclear extracts prepared from quiescent NIH 3T3 cells can be almost completely inhibited, together with the appearance of a faint supershift (Fig. 9, left panel) . The same result was obtained with extracts from serum-restimulated cells (data not shown). Anti-CREB-1 or anti-CREM antibodies were ineffective in reproducibly displacing the same complexes, thus suggesting that ATF-1 is a major effector for this element.
As far as the NF-1/NF-Y element is concerned, it turned out (28) . Antibodies directed against both the A and the B subunits were able to supershift the specific complex formed in vitro with the cyclin A NF-1/NF-Y element and extracts from both quiescent (Fig. 9 , right panel) and serumstimulated NIH 3T3 cells (data not shown). Several DNA protein complexes were clearly visible with the cyclin A CCRE motif and extracts prepared from both cycling and quiescent cells. They were competed out by a 100-fold molar excess of the nonradioactive probe (Fig. 10) , and no competition was observed with the mutated oligonucleotide. Complexes with higher mobility were seen with extracts from S-phase-enriched cells (Fig. 10, lanes 1 to 3) . Because of its GC richness, the binding of the cyclin A probe to purified Sp1 (generous gift from J. Imbert) was assayed and compared with that of an oligonucleotide containing SV40 Sp1 motifs. Whereas a clearly detectable set of retarded complexes was observed with the SV40 probe, the cyclin A probe did not give rise to appreciable binding (data not shown). This result was confirmed by the use of specific anti-SP1 antibodies. They prevented almost completely the formation of complexes with the Sp1 probe, while leaving complexes formed on the cyclin A probe unaffected (Fig. 10) .
The cyclin A CCRE contains within its core the motif TCGCG which is present within the consensus E2F sequence. E2F proteins are an expanding family of transcription factors which form heterodimeric complexes with members of the DRTF1/DP-1 family (30, 35, 55) . The E2F/DP complex is functionally regulated by its phosphorylation and by the binding to one or more of the structurally related Rb, p107, and p130 proteins (for reviews, see references 24, 27, 35, 45, 69) . E2F-1, E2F-2, and E2F-3 form complexes with Rb, whereas E2F-4 and E2F-5 specifically bind to p107 and p130 (for a FIG. 5 . Differential occupancy of the GC-rich site in early versus late G 1 phase of the cell cycle. Friend cells were blocked prior to mitosis by a 9.5-h treatment with 100 nM demecolcine and were then released by extensive washing. Progression in the cell cycle was monitored by FACS analysis (upper panel). Cells were methylated with DMS at the indicated times after release and were sorted according to their DNA contents to focus on the G 1 population. The cells were then processed for genomic footprinting as described in Materials and Methods. The autoradiograms were scanned for densitometry, and the integrated intensities of the bands labeled A in Fig. 4 were normalized for each point by using the integrated densities of bands S1 and S2 surrounding the GC-rich site and taken as internal standards. These values which were plotted in the lower panel, can be compared with the means and 95% confidence limits obtained for 3 to 13 different ligation-mediated PCRs carried out on naked DNA as well as for the DNAs prepared from G 1 and G 2 /M cells.
FIG. 6.
Differential occupancy of the GC-rich site in proliferating versus differentiating Friend cells. Cells were exposed to 1.5% (vol/vol) DMSO, and the percentages of hemoglobin-producing cells, counted as benzidine positive (plotted at the top), were evaluated daily (F) and were compared with those of cells grown without the inducer (E). Cells were harvested at the indicated times, treated with DMS, and processed for genomic footprinting as described in the legend to Fig. 4. 
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on February 21, 2013 by PENN STATE UNIV http://mcb.asm.org/ review, see reference 45). A current model proposes that each of these pocket proteins interacts with the various E2Fs in defined periods of the cell cycle. Anti-E2F-1, -4, and -5 antibodies were thus used successively without any reproducible effect on the mobilities of the various complexes, regardless of whether the extracts were prepared from quiescent cells ( Fig. 10 ; only the result with anti-E2F-1 is shown) or from serum-stimulated cells (data not shown). Conversely, the same antibodies were able to recognize their cognate in vitro-synthesized E2F proteins (data not shown), and each displaced a specific subset of the complexes formed by a consensus E2F oligonucleotide (Fig. 10) . Moreover, a 100-fold molar excess of the consensus E2F oligonucleotide failed to displace the complexes from the cyclin A CCRE. Finally, mobility shift assays were carried out with recombinant proteins synthesized in vitro in the rabbit reticulocyte lysate. No binding on the cyclin A probe was observed, whereas DP-1 in combination with E2F-1, -4, or -5 gave rise to specific retarded bands with the consensus E2F probe (Fig. 11) .
DISCUSSION
Numerous studies have shown that cyclin A mRNA accumulation is cell cycle regulated by a transcriptional activation of its gene in the late G 1 phase of the cell division cycle (6, 25) . Therefore, we have undertaken the analysis of sequences and factors involved in the control of the expression of both the human and mouse cyclin A genes. Complexes formed with 5 g of nuclear extracts were resolved in 5% polyacrylamide gels as described in Materials and Methods. The gels were fixed in an acetic acid-ethanol-water mixture (1:1:8), dried, and then exposed for autoradiography. Only retarded bands are shown. wt and m, 100-fold molar excess of, respectively, wild-type and mutated unlabeled corresponding oligonucleotides added in the reaction mixture (2, 3, 8, 9) . When indicated, specific antibodies directed against CREB (4), ATF-1 (5), CREM (6), Y A (10) , and Y B (11) subunits of NF-Y were added 1 h prior to the addition of the probe. Arrows, specific complexes (on the left) and supershifted bands (on the right); asterisk, unspecific complexes. Probes incubated alone or in the presence of antibodies did not produce retarded bands (data not shown).
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on February 21, 2013 by PENN STATE UNIV http://mcb.asm.org/ characterized the structure of the mouse cyclin A gene. Comparison of the sequences of the human and mouse promoters revealed the presence of a region of striking homology containing a CRE, a NF-Y-binding site, and a GC-rich motif. Our previous work on cyclin A down-regulation by TGF-␤ had pointed to the CRE as an important mediator of the inhibitory effect of the cytokine (5, 6). However, a promoter which was mutated on the CRE was still able to respond to serum stimulation, albeit at a lower efficiency. A close examination by DMS footprinting of the pattern of protein binding in vivo to this region revealed the presence of complexes in the vicinity of the major transcription initiation sites. Whereas the CRE and the NF-Y sites were occupied throughout the cell cycle, the occupancy of the GC-rich site was specifically observed in quiescent as well as early G 1 cells, when cyclin A gene is transcriptionally silent. Moreover, the same result was obtained in normal human fibroblasts rendered quiescent either by serum starvation or by exposure to TGF-␤, which is known to arrest cells in G 1 . This raised the possibility of the binding of a repressor type of complex to this region. This prompted us to mutate the conserved GC-rich motif and assess the serum responsiveness of the resulting promoter in quiescent cells restimulated with serum. Mutation of the GC-rich sequence led to a 10-fold increase in reporter activity and almost totally impaired its cell cycle-dependent activation, thus confirming its negative regulatory role. We then transferred the CCRE into the early SV40 enhancerless promoter, which is not naturally cell cycle responsive. Whereas the CCRE alone decreased dramatically the efficiency of the SV40 promoter, it did not endow it with a cell cycle-dependent transcriptional activity. However, the addition of surrounding sequences, spanning the entire conserved region, restored the expected behavior. This result thus suggests a cooperation between neighboring sequences and the CCRE which, in their absence, may function only as a constitutive negative regulatory element. The presence of a constitutive in vivo footprint on both the CRE and the NF-Y sites nearby points to their possible involvement in modulating the CCRE activity. Interestingly, several recent reports have stressed the importance of the CRE in mediating cyclin A gene expression in human Hs27 (16) or hamster CCL39 fibroblasts (6), as well as in bovine aortic endothelial cells (72) . Despite the presence of serum, TGF-␤1 treatment of CCL39 cells (5, 6) or contact inhibition of bovine aortic endothelial cells (72) led to a down-regulation of cyclin A, which in both cases was mediated by the CRE. This opens an interesting possibility of cooperation between these different motifs, whereby one of the elements (the CRE?) would integrate signals generated at the cell periphery (cell anchorage, contact inhibition, TGF-␤, etc.) and the other one (the CCRE?) would control a proper cell cycle-dependent expression of cyclin A. The data presented in this paper are reminiscent of previous studies conducted with the promoters of the human cdc2 (14, 64) , E2F-1 (44) , and cdc25C (40) genes, as well as with the mouse B-myb (34) gene. All of these genes are expressed either during the G 1 /S or the G 2 /M transition of the cell division cycle. Their promoters have also been reported to be negatively regulated in G 0 /G 1 through GC-rich motifs. The involvement of the E2F family of transcription factors has been strongly substantiated for the regulation of cdc2, E2F-1, and B-myb genes. However, its participation in the control of cdc25C transcription appears unlikely, since biochemically purified E2F did not show any in vitro affinity for the cdc25C regulatory element (40) . The same situation seems to hold in the case of the cyclin A promoter. Antibodies directed against E2F-1, -4, or -5 did not prevent proteins from binding in vitro to a CCRE probe when reacted with nuclear extracts from FIG. 10 . Protein complexes formed in vitro with the cyclin A CCRE or control SP1 and E2F oligonucleotides. Gel shifts were carried out with cyclin A CCRE or Sp1 and E2F consensus oligonucleotides as indicated in the legend to Fig. 9 . Nuclear extracts were prepared from either 18-h serum-stimulated cells (lanes 1 to 3) or quiescent NIH 3T3 cells (lanes 4 to 17). As controls, the probes were incubated in the presence of a 100-fold molar excess of an unlabeled corresponding oligonucleotide harboring a wild-type (wt) (lanes 2, 5, and 17) or a mutated (m) sequence (lanes 3, 6, and 16). In the case of the CCRE, a competition assay with the E2F oligonucleotide was also performed (E2F) (lane 7). When indicated, extracts were incubated with antibodies directed against Sp1 (lanes 8 and 11), E2F-1 (lanes 7 and 13), E2F-4 (lane 14), or E2F-5 (lane 15), which were added at room temperature 1 h prior to electrophoresis. Symbols are as described in the legend to Fig. 9.   FIG. 11 . Comparative binding of in vitro-synthesized E2Fs and DP-1 proteins to the CCRE and E2F oligonucleotides. The consensus E2F and CCRE radioactive probes were incubated with proteins synthesized in the rabbit reticulocyte lysate as indicated. UP, stands for unprogrammed lysate. The specificities of the complexes formed with the E2F probe were assessed by a competition assay with a 100-fold molar excess of unlabeled E2F oligonucleotide (ϩ). Separation of the complexes was as described in the legend to Fig. 9. either quiescent or serum-stimulated cells. Whereas proteins binding in vitro to the upstream elements have unambiguously been identified as, respectively, ATF-1 and NF-Y, we have not been able to identify those binding in vitro to the cyclin A CCRE.
After completion of this work, two reports (57, 75) reached the same conclusion about the role of the CCRE in controlling the cell cycle behavior of the cyclin A promoter. However, they disagreed about the nature of the protein(s) binding in vitro to this sequence. Therefore, this leaves open the possibility of the presence of either a distantly related member of the E2F family, harboring a very low in vitro affinity for the cyclin A CCRE, or another factor that has not yet been identified. Interestingly, in support of the first hypothesis, cyclin A mRNA accumulation is greatly enhanced in adenovirus E1A-transformed rodent cell lines (7) . Overexpression of viral proteins such as adenovirus E1A or SV40 T, which are known to complex RB-like proteins, releases E2F from this inhibitory interaction (12, 29, 41, 58, 73, 74) . Moreover, a recent report based on the use of a recombinant adenovirus expressing E2F-1 points to cyclin A as one of the putative cellular targets of this transcription factor (15) . Should members of the E2F family be involved either directly or indirectly in the regulation of cyclin A expression, this would provide the cell with an interesting feedback loop. On the one hand, E2F type factors would exchange on the cyclin A promoter as resting cells proceed through the cell cycle. As a result, an inhibitory transcriptional complex would be switched into an active one. On the other hand, cyclin A/cdk2 has been reported to bind directly to E2F-1, inhibiting the DNA-binding activity of E2F-1/DP-1 by phosphorylation.
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